Published in Clin Exp Immunol on October 01, 1979
Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest (1994) 1.51
Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Ann Rheum Dis (1995) 0.98
Short-term exposure of Chinook salmon (Oncoryhnchus tshawytscha) to o,p-DDE or DMSO during early life-history stages causes long-term humoral immunosuppression. Environ Health Perspect (2003) 0.77
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol (1971) 3.49
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro. Biochim Biophys Acta (1968) 1.20
Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res (1975) 1.18
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
The autoimmune response to male reproductive tissues of rabbits. III. Effects of testosterone and estrogen on cryoimmunogenic and immunochemical expressions of the central accessory glands. Invest Urol (1974) 1.08
Management of stage C prostatic carcinoma. Urol Clin North Am (1975) 0.92
Precursors of corpus cancer. III. The appearance of cancer of the endometrium in estrogenically conditioned patients. Obstet Gynecol (1961) 0.89
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Biopsy and clinical course after cryosurgery for prostatic cancer. J Urol (1978) 0.78
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity. Eur J Cancer (1979) 0.78
Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy. J Reticuloendothel Soc (1979) 0.78
Hormonal epidemiology of prostatic cancer. Med J Aust (1977) 0.77
Aetiology of Kaposi's sarcoma. Lancet (1990) 1.95
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Primary renal sarcoma in adults. A natural history and management study by the American Cancer Society, Illinois Division. Cancer (1993) 1.12
Thymus-specific antigens on human thymocytes and on thymic-derived lymphocytes. Transplantation (1973) 1.10
IgE in pemphigus. Arch Dermatol (1977) 1.09
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
Precipitating antigens of the normal human prostate. J Reprod Fertil (1970) 1.04
Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Exp Med Surg (1969) 0.98
Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma (1971) 0.97
Blood product immunosuppression and the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.97
Prostate cancer in Illinois. IMJ Ill Med J (1984) 0.93
Alterations of alpha2-globulin and the clinical response in patients with prostatic cancer following cryotherapy. Oncology (1975) 0.91
Localization of immunoglobulins in human prostatic tissue. J Immunol (1971) 0.90
Tissue- and species-specific antibodies in antithymocyte globulin. Transplantation (1972) 0.90
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female. Histol Histopathol (2000) 0.87
Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol (1969) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
Condylomata acuminata: treatment by autogenous vaccine. IMJ Ill Med J (1975) 0.87
Cancer, immunological surveillance, and 2 -globulin. Lancet (1972) 0.86
The significance of L forms in human renal disease. J Urol (1972) 0.86
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
Immunopathologic studies of experimental pemphigus-like autoantibodies and bullous-like lesions. J Invest Dermatol (1969) 0.83
Transglutaminase: co-factor in aetiology of AIDS? Lancet (1985) 0.83
A retrospective look at studies on prostate-specific antigen. Clin Chem (1985) 0.82
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
A tissue type transglutaminase in human seminal plasma. Am J Reprod Immunol (1997) 0.82
Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res (1986) 0.82
In vivo bound immunoglobulins in the human prostate--their identification and possible significance. Z Immunitatsforsch Exp Klin Immunol (1972) 0.82
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
Autoallergy in pemphigus. Lancet (1968) 0.81
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost (1988) 0.81
Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms. Arch Dermatol (1974) 0.81
Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J Urol (1994) 0.81
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Immunologic sequelae of thermal injury. I. Frequency and relationship of epithelial antibodies to extent of burn. Clin Immunol Immunopathol (1976) 0.81
Fluorescent studies of antibodies to rabbit male urogenital tissue. Experientia (1969) 0.81
Freezing of the esophagus: histological changes and immunological response. Int Surg (1982) 0.81
Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate. Z Immunitatsforsch Exp Klin Immunol (1973) 0.81
The projection of the cervical disc and uncinate process on the posterior aspect of the cervical spine. Surg Neurol (1999) 0.80
Absorption studies on antigen(s) of the esophageal mucosa reactive with autoantibodies of pemphigus. Int Arch Allergy Appl Immunol (1968) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Selective deficiency of IgA. Lancet (1971) 0.79
Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Urology (1973) 0.79
Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang (1972) 0.79
Androgens and oestrogens may modulate the growth and function of lymphoid organs. J Immunol (1984) 0.79
Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.79
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer. Am J Reprod Immunol (1981) 0.79
Immunofluorescent identification of a human thymic specific antigen. Blut (1974) 0.78
Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy. J Reticuloendothel Soc (1979) 0.78
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity. Eur J Cancer (1979) 0.78
The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues. Gen Physiol Biophys (1999) 0.78
Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls. J Surg Oncol (1974) 0.78
Cell-mediated immunity in prostatic cancer. Clin Oncol (1980) 0.78
Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy. Indian J Exp Biol (1982) 0.78
Effect of cyclophosphamide on leukocytic subset distributions in rats carrying the Dunning R3327-MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.78
Cellular immunity in bladder cancer patients. J Urol (1978) 0.78
Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis. Urol Res (1974) 0.78
Experimental concurrence of pemphigus-like autoantibodies and bullous-like lesions. A preliminary report. Jpn J Med Sci Biol (1969) 0.78
HIV-related protein in the prostate: a possible reservoir of virus. Am J Clin Pathol (1991) 0.78
Immunologic studies of patients with pulmonary emphysema. Ann Allergy (1973) 0.78
Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma. J Urol (1974) 0.78
Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer. Allergol Immunopathol (Madr) (1976) 0.78
A possible immuno-cryothermic response in prostatic cancer. Clin Radiol (1970) 0.77
Malignancy associated with antinuclear antibodies. Lancet (1972) 0.77
The case against "the case against the catheter": initial report. J Urol (1969) 0.77
Cryoimmunotherapy. Br Med J (1972) 0.77
Cytotoxic antibodies to allogenic lymphocytes in prostatic cancer. JAMA (1972) 0.77
Impotence therapy and cancer of the prostate. Am J Surg (1976) 0.77
Hormonal epidemiology of prostatic cancer. Med J Aust (1977) 0.77
Immunologic studies of the prostate. A review. Int Surg (1969) 0.77
Sperm-induced urolithiasis in the rat. Eur J Epidemiol (1994) 0.77